Cryo-Cell International (CCEL) Institutional Ownership $4.41 +0.03 (+0.68%) As of 11:59 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Cryo-Cell International (NYSEAMERICAN:CCEL)CurrentInstitutional OwnershipPercentage10.44%Number ofInstitutional Buyers(last 12 months)6Number ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$70.64K Get CCEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cryo-Cell International stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CCEL Institutional Buying and Selling by Quarter Cryo-Cell International Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Topline Capital Management LLC40,553$210K0.0%-15.1%0.503% 5/14/2025CreativeOne Wealth LLC10,117$64K0.0%-33.9%0.126% 2/14/2025Northern Trust Corp38,902$288K0.0%+78.2%0.483% 2/14/2025Topline Capital Management LLC47,791$354K0.1%N/A0.593% 2/13/2025CreativeOne Wealth LLC15,310$113K0.0%N/A0.190% 2/11/2025Heron Bay Capital Management31,766$235K0.0%N/A0.394% 2/4/2025Rowlandmiller & PARTNERS.ADV14,433$107K0.0%N/A0.179% 11/16/2024Geode Capital Management LLC39,860$254K0.0%+68.5%0.495% 4/9/2024Massmutual Trust Co. FSB ADV111,035$828K0.0%-2.8%1.339% 4/8/2024Rowlandmiller & PARTNERS.ADV14,433$108K0.0%N/A0.174% 1/3/2024Massmutual Trust Co. FSB ADV114,213$657K0.0%-8.0%1.378% 2/9/2023Hamilton Lane Advisors LLC409,734$1.73M0.6%N/A4.810% 8/15/2022Iszo Capital Management LP353,210$2.08M3.3%-1.1%4.211% 7/7/2022Massmutual Trust Co. FSB ADV124,135$732K0.0%+63.3%1.467% 5/16/2022Iszo Capital Management LP357,107$2.73M3.2%-26.1%4.221% 2/15/2022SFI Advisors LLC165,300$1.57M1.4%N/A1.938% 2/14/2022Rowland & Co. Investment Counsel ADV11,000$128K0.0%N/A0.129% 11/15/2021HighTower Advisors LLC12,761$155K0.0%N/A0.150% 11/15/2021Maryland Capital Management19,563$237K0.0%N/A0.229% 11/3/2021Seizert Capital Partners LLC43,483$527K0.0%-4.6%0.510% (Data available from 1/1/2016 forward) CCEL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CCEL shares? During the previous two years, the following institutional investors and hedge funds held shares of Cryo-Cell International shares: Massmutual Trust Co. FSB ADV ($828K), Northern Trust Corp ($288K), Geode Capital Management LLC ($254K), Heron Bay Capital Management ($235K), Topline Capital Management LLC ($210K), and Rowlandmiller & PARTNERS.ADV ($107K), and CreativeOne Wealth LLC ($64K).Learn more on Cryo-Cell International's institutional investors. What percentage of Cryo-Cell International's stock is owned by institutional investors? 10.44% of Cryo-Cell International's stock is owned by institutional investors. Learn more on CCEL's institutional investor holdings. Which institutional investors have been buying Cryo-Cell International's stock? The following institutional investors have purchased Cryo-Cell International's stock in the last 24 months: Topline Capital Management LLC ($47.79K), Heron Bay Capital Management ($31.77K), Rowlandmiller & PARTNERS.ADV ($28.87K), Northern Trust Corp ($17.07K), Geode Capital Management LLC ($16.20K), and CreativeOne Wealth LLC ($15.31K). How much institutional buying is happening at Cryo-Cell International? Institutional investors have bought a total of 142,569 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which of Cryo-Cell International's major shareholders have been selling company stock? The following institutional investors have sold Cryo-Cell International stock in the last 24 months: Topline Capital Management LLC ($7.24K), and CreativeOne Wealth LLC ($5.19K). How much institutional selling is happening at Cryo-Cell International? Institutional investors have sold a total of 12,431 shares in the last 24 months. This volume of shares sold represents approximately $70.64K in transactions. Related Companies Sera Prognostics Major Shareholders Quipt Home Medical Major Shareholders Burning Rock Biotech Major Shareholders Biodesix Major Shareholders P3 Health Partners Major Shareholders EUDA Health Major Shareholders Kindly MD Major Shareholders Basel Medical Group Major Shareholders Mangoceuticals Major Shareholders American Shared Hospital Services Major Shareholders This page (NYSEAMERICAN:CCEL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.